Home » Newsletters » BioWorld Science

BioWorld Science

June 29, 2001

View Archived Issues

Licensing opportunity from NIH: plasmid for production of more soluble form of HIV integrase protein

FDA approves new formulation of Reminyl

FluMist review by advisory committee scheduled for late July

Favorable delivery characteristics, therapeutic effects reported in humans for inhaled insulin

Pharmacokinetics of AERx iDMS compared in smokers and nonsmokers

Novel insulin formulations from Coremed highlighted at ENDO 2001

Xenical to be used in NIH-funded study on weight loss and diabetes

Pharmexa in-licenses PADRE technology from Epimmune

Immunomedics and IBC report on bispecific antibody studies

MitoKor acquires Apollo BioPharmaceutics

Osteoblast-stimulating activity reported for carnitine derivatives

Milkhaus begins clinical testing of ML-04 for chronic prostatitis

Preclinical results obtained by VaxGen suggest feasibility of broadly protective HIV vaccine

AZ-242, a novel PPARalpha/PPARgamma activator for insulin resistance syndrome, type 2 diabetes

Theratechnologies begins second phase II trial in sleep disorders; phase IIa results promising

Patient enrollment completed in phase II trial of Axonyx's phenserine

Complementary antihypertensive effect seen for farglitazar in rats and humans

E.C. approves Actiq via mutual recognition procedure

Health Canada grants approval for Crohn's disease treatment

ADA news: SGLT inhibitor RWJ-394718 has favorable effects in rodent models of type 2 diabetes

Lilly Icos seeks FDA approval of Cialis for erectile dysfunction

New data for Gleevec show increase in CML response rates over time

Combination therapies for certain malignancies discussed by Idec

Antiviral combination therapy of HBV reported by Glaxo

Acylsulfonamides as selective chymase inhibitors

Agents for H. pylori infections designed by AstraZeneca to have improved stability

Biogen presents new series with particular utility in CHF, renal dysfunction

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...